Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
InMode Ltd.

InMode Ltd. (INMD) Stock Overview

Explore InMode Ltd.’s financial performance, market position, analyst ratings, and future outlook.

INMD●NASDAQ
HealthcareMedical - Devices
$15.20
$0.03(0.20%)
U.S. Market opens in 3h 2m

InMode Ltd. (INMD)

Meyka AI Score

Z

Key Financials

Market Cap873.7M
P/E Ratio12.16
EPS (TTM)$1.44
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$16.08
3 Months$17.93
1 Year Target$12.77

INMD Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of InMode Ltd. (NASDAQ: INMD) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, InMode Ltd.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of INMD on the NASDAQ shows an RSI of 53.68, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $12.77 for the NASDAQ listing.

Key metrics behind InMode Ltd.'s NASDAQ-traded stock include a P/E ratio of 12.16 and a market capitalization of 873.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of INMD on the NASDAQ.

Price Performance (NASDAQ: INMD)

1-Day Change
-0.20%
5-Day Change
0.66%
1-Month Change
0.33%
3-Month Change
8.26%
6-Month Change
6.29%
Year-to-Date (YTD) Change
3.47%
1-Year Change
3.75%
3-Year Change
-62.98%
5-Year Change
-72.01%
All-Time (Max) Change
123.86%

Contact Information

https://www.inmodemd.com
972 4 909 6313
Tavor Building, Yokne'am, TA, 2069206

Company Facts

6,600 Employees
IPO DateAug 8, 2019
CountryIL
Actively Trading

Frequently Asked Questions